The porous polyethylene (Medpor) spherical orbital implant: A retrospective study of 136 cases

Ophthalmic Plastic and Reconstructive Surgery

Volumn 19, Issue 5, 2003, Pages 364-371

  Blaydon, Sean M ^a,b,c,d   Shepler, Todd R ^a,e   Neuhaus, Russell W ^a,b   White, William L ^f   Shore, John W ^a  

^a Texas Oculoplastic Consultants   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c Army Medical Department Center and School   (United States)

^d BROOKE ARMY MEDICAL CENTER   (United States)

^e Brackenridge Hospital   (United States)

^f UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDPOR; POLYETHYLENE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CONTROLLED STUDY; ENUCLEATION; EVISCERATION; EYE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORBIT IMPLANT; ORBIT RECONSTRUCTION; POROSITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOTHERAPY; REOPERATION; RISK FACTOR; SEX DIFFERENCE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOCOMPATIBLE MATERIALS; CHILD; CHILD, PRESCHOOL; EYE ENUCLEATION; EYE EVISCERATION; FEMALE; HUMANS; MALE; MIDDLE AGED; ORBITAL IMPLANTS; POLYETHYLENES; POSTOPERATIVE COMPLICATIONS; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0141508935     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.IOP.0000083643.36461.84     Document Type: Article

References (35)

1. Perry AC. Integrated orbital implants. Adv Ophthal Plast Reconstr Surg 1990;8:75-81.
2. Perry AC. Advances in enucleation. Ophthalmol Clin North Am 1991;4:173-82.
3. Shields CL, Shields JA, De Potter P, Singh AD. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases. Trans Am Ophthalmol Soc 1993;91:177-95.
4. Goldberg RA, Holds JB, Ebrahimpour J. Exposed hydroxyapatite orbital implants. Ophthalmology 1992;99:831-6.
5. Buettner H, Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol 1992;113:669-73.
6. Shields CL, Shields JA, De Potter P, et al. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases. Trans Am Ophthalmol Soc 1993;91:177-95.
7. Goldberg RA, Holds JB, Ebrahimpour J. Exposed hydroxyapatite orbital implants. Ophthalmology 1992;99:831-6.
8. Buettner H, Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol 1992;113:669-73.
9. Nunery WR, Heinz GW, Bonnin JM, et al. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal Plast Reconstr Surg 1993;9:96-104.
10. Jordan DR. The popping peg phenomenon. Arch Ophthalmol 1994;112:300-1.
11. Shields CL, Shields JA, De Potter P, et al. Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases. Br J Ophthalmol 1994;78:702-6.
12. El-Shahed FS, Sherif MM, Ali AT. Management of tissue break-down and exposure associated with orbital hydroxyapatite implants. Ophthal Plast Reconstr Surg 1995;11:91-4.
13. Kaltreider SA, Newman SA. Prevention and management of complications associated with the hydroxyapatite implant. Ophthal Plast Reconstr Surg 1996;12:18-31.
14. Remulla HD, Rubin PA, Shore JW, et al. Complication of porous spherical orbital implants. Ophthalmology 1995;102:586-93.
15. Choi JC, Iwamoto MA, Bstandig S, et al. Medpor motility coupling post: a rabbit model. Ophthal Plast Reconstr Surg 1999;15:190-201.
16. Shields CL, Shields JA, De Potter P. Hydroxyapatite orbital implant after enucleation: experience with initial 100 consecutive cases. Arch Ophthalmol 1992;110:333-8.
17. Shields JA, Shields CL, De Potter P. Hydroxyapatite orbital implant after enucleation: experience with 200 cases. Mayo Clin Proc 1993;68:1191-5.
18. Dutton JJ. Coralline hydroxyapatite as an ocular implant. Ophthalmology 1991;98:370-7.
19. Rubin LR. Polyethylene as a bone and cartilage substitute: a 32-year retrospective. In: Rubin LR, ed. Biomaterials in Reconstructive Surgery. St. Louis: CV Mosby; 1983:474-93.
20. Bilyk JR, Rubin PAD, Shore JW. Correction of enophthalmos with porous polyethylene implants. Int Ophthalmol Clin 1992;32:151-5.
21. Karesh JW, Dresner SC. High-density porous polyethylene (Medpor) as a successful anophthalmic socket implant. Ophthalmology 1994;101:1688-95.
22. Klawitter JJ, Bagwell JG, Weinstein AM, et al. An evaluation of bone growth into porous high-density polyethylene. J Biomed Mater Res 1976;10:311-23.
23. Spector M, Flemming WR, Kreutner A. Bone growth into porous high-density polyethylene. J Biomed Mater Res 1976;10:595-603.
24. Merritt K, Shafer JW, Brown SA. Implant site infection rates with porous and dense materials. J Biomed Mater Res 1979;13:101-8.
25. Rubin PA, Popham JK, Bilyk JR, et al. Comparison of fibrovascular ingrowth into hydroxyapatite and porous polyethylene orbital implants. Ophthal Plast Reconstr Surg 1994;10:96-103.
26. Goldberg RA, Dresner SC, Braslow RA, et al. Animal model of porous polyethylene orbital implants. Ophthal Plast Reconstr Surg 1994;10:104-9.
27. Bigham WJ, Stanley P, Cahill JM, et al. Fibrovascular ingrowth in porous implants: the effect of material composition, porosity, growth factors, and coatings. Ophthal Plast Reconstr Surg 1999;15:317-25.
28. McNab A. Hydroxyapatite orbital implants: experience with 100 cases. Aust N Z J Ophthalmol 1995;23:117-23.
29. Oestreicher JH, Liu E, Berkowitz M. Complications of hydroxyapatite orbital implants: a review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) and scleral wrapping. Ophthalmology 1997;104:324-29.
30. Kostick DA, Linberg JV. Evisceration with hydroxyapatite implant: surgical technique and review of 31 case reports. Ophthalmology 1995;102:1542-8.
31. Yang JG, Khwarg SI, Wee WR, et al. Hydroxyapatite implantation with scleral quadrisection after evisceration. Ophthal Surg Lasers 1997;28:915-9.
32. Shields CL, Shields JA, Eagle RC Jr, et al. Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant. Am J Ophthalmol 1991;111:363-6.
33. De Potter P, Duprez T, Cosnard G. Postcontrast magnetic resonance imaging assessment of porous polyethylene orbital implant (Medpor). Ophthalmology 2000;107:1656-60.
34. Holck DE, Dutton JJ, Proia A, et al. Rate of vascularization of coralline hydroxyapatite spherical implants pretreated with saline/gentamicin, rTGF-beta 2, and autogenous plasma. Ophthal Plast Reconstr Surg 1998;14:73-80.
35. Ashworth JL, Rhatigan M, Sampath R, et al. The hydroxyapatite orbital implant: a prospective study. Eye 1996;10:29-37.